Tchitchkan, E., Zhong, C., Xie, W., Anumolu, R., Stoltenberg, H., Rider, R., Ritzer, J., Wolanski, A., Takakura, A., Bonventre, J., Jacene, H., Gupta, S., Ravi, P. (2026). Renal outcomes following
                    <sup>177</sup>
                    Lu-PSMA-617 (LuPSMA) in patients with metastatic castration-resistant prostate cancer (MCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.138